Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Sulfasalazine-induced agranulocytosis is associated with the human leukocyte antigen locus

  • In: Short Communications E1 on Monday, 22 May 2017, 13:30-15:00
  • At: Stockholm (Sweden) (2017)
  • Type: Presentation
  • By: WADELIUS, Mia (Uppsala University, Medical Sciences, Clinical Pharmacology, Uppsala, Sweden)
  • Co-author(s): Mia Wadelius: Department of Medical Sciences and Science for Life Laboratory, Uppsala University, Uppsala , Sweden
    Niclas Eriksson: Medical Sciences, Uppsala University, Uppsala, Sweden;Uppsala Clinical Research Center, Uppsala Region, Uppsala, Sweden
    Reinhold Kreutz: Charité - Universitätsmedizin Berlin, Institut für Klinische Pharmakologie und Toxikologie, Berlin, Germany
    Emmanuelle Bondon-Guitton: Service de Pharmacologie Médicale et Clinique, Faculté de Médecine de l'Université de Toulouse, Toulouse, France
    Luisa Ibañez: Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
    Alfonso Carvajal: Centro de Estudios sobre la Seguridad de los Medicamentos, Universidad de Valladolid, Valladolid, Spain
    M. Isabel Lucena: Instituto de Investigación Biomédica de Málaga, University of Málaga, Málaga, Spain
    Esther Sancho Ponce: Servei d'Hematologia i Banc de Sang, Hospital General de Catalunya, Sant Cugat del Vallès, Spain
    Mariam Molokhia: NIHR Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation, King's College London, London, United Kingdom
    Javier Martin: Instituto de Parasitologia y Biomedicina Lopez-Neyra, CSIC, Granada, Spain
    Tomas Axelsson: Department of Medical Sciences and Science for Life Laboratory, Uppsala University, Uppsala , Sweden
    Hugo Kohnke: Department of Medical Sciences and Science for Life Laboratory, Uppsala University, Uppsala , Sweden
    Qun-Ying Yue: Medical Products Agency, Swedish State Authority, Uppsala, Sweden
    Patrik K. E. Magnusson: Swedish Twin Registry, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Mats Bengtsson: Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Pär Hallberg: Department of Medical Sciences and Science for Life Laboratory, Uppsala University, Uppsala , Sweden
  • Abstract:

    Backgrounds

    Agranulocytosis is a serious rare adverse reaction to sulfasalazine, which is used to treat inflammatory joint and bowel disease. The reaction is believed to be immune-mediated, but risk factors are unknown.

     

    Aims

    The European Drug-induced Agranulocytosis Consortium (EUDAC) aimed to find genetic risk factors for

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses